Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Exchange Rate Effect (2019 - 2025)

Summit Therapeutics (SMMT) has disclosed Exchange Rate Effect for 7 consecutive years, with -$19000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 82.41% year-over-year to -$19000.0, compared with a TTM value of $102000.0 through Dec 2025, up 666.67%, and an annual FY2025 reading of $102000.0, up 666.67% over the prior year.
  • Exchange Rate Effect was -$19000.0 for Q4 2025 at Summit Therapeutics, down from $22000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.4 million in Q4 2022 and bottomed at -$1.8 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is $2600.0, with a median of $17000.0 recorded in 2024.
  • Peak annual rise in Exchange Rate Effect hit 428.16% in 2022, while the deepest fall reached 621.74% in 2022.
  • Year by year, Exchange Rate Effect stood at -$419000.0 in 2021, then surged by 428.16% to $1.4 million in 2022, then crashed by 80.22% to $272000.0 in 2023, then crashed by 139.71% to -$108000.0 in 2024, then skyrocketed by 82.41% to -$19000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for SMMT at -$19000.0 in Q4 2025, $22000.0 in Q3 2025, and $61000.0 in Q2 2025.